Target intelligence / Profile preview

Pasteurella multocida antigens (P. multocida antigens)

Target
P. multocida antigens
Molecular classification
Bacterial protein, Polysaccharide, Endotoxin, Bacterial toxin
01

Overview

Pasteurella multocida antigens are a complex group of molecular structures derived from the Gram-negative bacterium Pasteurella multocida, which causes various severe diseases in livestock and poultry, including fowl cholera and hemorrhagic septicemia (Harper et al., 2006). These antigens primarily include capsular polysaccharides (CPS), which are essential for serogrouping (A, B, D, E, and F) and immune evasion, and lipopolysaccharides (LPS) that contribute to the inflammatory response and endotoxicity (Boyce et al., 2012). Additionally, outer membrane proteins (OMPs) such as OmpA and OmpH are significant targets for the host protective immune response due to their conservation across strains (Hatfaludi et al., 2010). In certain strains, the Pasteurella multocida toxin (PMT) acts as a potent mitogen and virulence factor, making it a critical component for toxoid-based vaccines (Wilson and Ho, 2013). These antigens are utilized in the development of bacterins, subunit vaccines, and recombinant vaccines to stimulate the production of neutralizing antibodies and cellular immunity. The primary therapeutic challenge lies in the antigenic diversity of the species, which often necessitates the use of multivalent vaccines to ensure broad protection against different serotypes (Wilkie et al., 2012).

Other names
Pasteurella multocida surface antigensPasteurella multocida capsular antigensPasteurella multocida outer membrane proteinsPMT antigens
02

Mechanism of action

Induction of active immunity through the presentation of bacterial epitopes to B and T lymphocytes, leading to the production of neutralizing antibodies and immunological memory.

03

Biological functions

Immune responsePathogenesisAdhesionToxicityImmune evasion
04

Disease associations

InfectionHemorrhagic septicemiaAtrophic rhinitisFowl choleraPasteurellosis
05

Safety considerations

Endotoxin-mediated inflammatory responseInjection site reactionsSerotype-specific limited protectionAnaphylaxis
06

Interacting drugs

Pasteurella multocida vaccine

3 more in the full profile.

07

Biomarkers

Anti-Pasteurella multocida IgG titersPMT-specific antibodiesSerum agglutination titers

Beyond the preview

Go deeper on Pasteurella multocida antigens (P. multocida antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pasteurella multocida antigens (P. multocida antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call